Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN) fell 3.3% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The stock’s 50-day moving average is GBX 3.87 and its 200 day moving average is GBX 3.95. The stock has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insider Activity at Eden Research

In other Eden Research news, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.